Sale!

JAK2 Mutation Detection Panel Exons 12-15

Original price was: $300.Current price is: $226.

-25%

The JAK2 Mutation Detection Panel Exons 12-15 is a comprehensive genetic test that identifies specific mutations in the JAK2 gene associated with various blood disorders. This advanced diagnostic tool detects mutations in exons 12 through 15 of the JAK2 gene, which are crucial for diagnosing myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. The test utilizes Sanger Sequencing methodology for high accuracy and reliability. Results are typically available within 7-8 days from sample collection. This test is particularly important for patients presenting with unexplained elevated blood counts, abnormal blood cell production, or symptoms suggestive of bone marrow disorders. The discounted price for this comprehensive genetic analysis is $226 USD, providing accessible advanced diagnostics for patients across the United States.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

JAK2 Mutation Detection Panel Exons 12-15

Comprehensive Genetic Analysis for Blood Disorders

The JAK2 Mutation Detection Panel Exons 12-15 represents a cutting-edge genetic diagnostic tool designed to identify specific mutations in the Janus Kinase 2 (JAK2) gene. This comprehensive panel focuses on exons 12 through 15, which are critical regions where mutations frequently occur in various hematological malignancies. The JAK2 gene plays a pivotal role in cellular signaling pathways that regulate blood cell production, and mutations in this gene can lead to uncontrolled cell growth and proliferation.

What This Test Measures and Detects

This advanced genetic panel specifically targets and analyzes:

  • JAK2 V617F mutation detection
  • Mutations in exons 12, 13, 14, and 15 of the JAK2 gene
  • Various point mutations, insertions, and deletions
  • Genetic alterations affecting JAK-STAT signaling pathway

The test employs Sanger Sequencing methodology, considered the gold standard for mutation detection, providing exceptional accuracy and reliability in identifying even low-level mutations that might be missed by other methods.

Who Should Consider This Test

This genetic analysis is recommended for individuals presenting with:

  • Unexplained elevated hemoglobin or hematocrit levels
  • Persistent thrombocytosis (elevated platelet counts)
  • Symptoms suggestive of myeloproliferative neoplasms
  • Family history of blood disorders or hematological cancers
  • Abnormal bone marrow findings
  • Splenomegaly (enlarged spleen) without clear cause
  • Constitutional symptoms including fatigue, night sweats, or weight loss
  • Previous abnormal blood counts requiring further investigation

Clinical Benefits of JAK2 Mutation Testing

Undergoing JAK2 mutation analysis provides numerous clinical advantages:

  • Accurate Diagnosis: Enables precise identification of specific myeloproliferative disorders
  • Treatment Guidance: Results inform targeted therapy selection, including JAK inhibitors
  • Prognostic Information: Helps predict disease progression and potential complications
  • Disease Monitoring: Serves as a baseline for tracking treatment response
  • Family Risk Assessment: Provides insights into potential hereditary factors
  • Early Intervention: Facilitates timely management before complications develop

Understanding Your Test Results

Your JAK2 Mutation Detection Panel results will be interpreted by our expert genetic counselors and hematologists:

  • Positive Result: Indicates the presence of JAK2 mutations, confirming diagnosis of associated blood disorders and guiding targeted treatment approaches
  • Negative Result: Suggests absence of detectable JAK2 mutations, though other genetic testing may be recommended for comprehensive evaluation
  • Variant of Uncertain Significance: Rare genetic changes with unclear clinical implications requiring further evaluation

All results include detailed interpretation and recommendations for next steps in your diagnostic journey. Our genetic counseling team is available to discuss your results and answer any questions you may have about their implications for your health management.

Test Pricing and Availability

Test Component Price (USD)
JAK2 Mutation Detection Panel Exons 12-15 $300
Discounted Price $226

Nationwide Testing Availability

General Genetics Corporation provides comprehensive JAK2 mutation testing services across the United States. We have established testing facilities and collection centers in all major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and Illinois metropolitan area
  • Houston and Texas Gulf Coast
  • Phoenix and Arizona communities
  • Philadelphia and Pennsylvania region
  • San Antonio and South Texas
  • San Diego and California coastal areas
  • Dallas and North Texas
  • San Jose and Silicon Valley

Sample Collection and Processing

Sample Type: Bone Marrow or Peripheral Blood
Collection Method: EDTA Vacutainer (2ml)
Turnaround Time: 7-8 days
Testing Methodology: Sanger Sequencing

Pre-Test Instructions

The JAK2 Mutation Detection Panel (Exons 12-15) requires a physician’s prescription for testing. Prescription requirements do not apply for surgical cases, pregnancy-related testing, or individuals planning international travel. Please consult with your healthcare provider to determine if this test is appropriate for your specific clinical situation.

Schedule Your JAK2 Mutation Test Today

Take the first step toward accurate diagnosis and personalized treatment planning. Our experienced genetic specialists are ready to assist you with comprehensive testing and expert interpretation of your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or discuss your testing needs with our genetic counseling team.

Early detection and precise genetic analysis can make a significant difference in managing blood disorders effectively. Trust General Genetics Corporation for reliable, accurate, and comprehensive JAK2 mutation testing services across the United States.